Circulating Damage Marker Profiles Support a Neuroprotective Effect of Erythropoietin in Ischemic Stroke Patients

The German Multicenter EPO Stroke Trial, which investigated safety and efficacy of erythropoietin (EPO) treatment in ischemic stroke, was formally declared a negative study. Exploratory subgroup analysis, however, revealed that patients not receiving thrombolysis most likely benefited from EPO durin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ehrenreich, Hannelore, Kästner, Anne, Weissenborn, Karin, Streeter, Jackson, Sperling, Swetlana, Wang, Kevin K, Worthmann, Hans, Hayes, Ronald L, von Ahsen, Nico, Kastrup, Andreas, Jeromin, Andreas, Herrmann, Manfred
Médium: Artigo
Jazyk:Inglês
Vydáno: ScholarOne 2011
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321813/
https://ncbi.nlm.nih.gov/pubmed/21912808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00259
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky